Changes in Beneficial Ownership · 4
Arcus Biosciences, Inc.
RCUSNYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1783978603.xml
Filing details
- Report period
- 2026-07-09
- Issuer
- Arcus Biosciences, Inc.
- Issuer CIK
- 0001724521
- Trading symbol
- RCUS
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Jaen Juan C.
- Reporting owner CIK
- 0001422996
- Relationship
- Officer
- Officer title
- President
- Address
- C/O ARCUS BIOSCIENCES, INC., 3928 POINT EDEN WAY, HAYWARD, CA, 94545
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 2026-07-09 | S · Form 4 | 48,502[F1] | D | 30.053[F2] | 842,307 | I | By Trust |
| Common Stock | 2026-07-10 | S · Form 4 | 19,799[F1] | D | 28.608[F3] | 822,508 | I | By Trust |
| Common Stock | 2026-07-10 | S · Form 4 | 268[F1] | D | 29.397[F4] | 822,240 | I | By Trust |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Disposed
- I
- Indirect
Non-derivative holdings
| Security | Amount owned | Ownership |
|---|---|---|
| Common Stock | 378,291[F5] | D |
Table key
- D
- Direct
Footnotes
- F1
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.↩ 1↩ 2↩ 3
- F2
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.↩ 1
- F3
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.↩ 1
- F4
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $29.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.↩ 1
- F5
- Includes the unvested portion of the Reporting Person's RSU grants.↩ 1
Signature 1
- Signed
- /s/ Carolyn Tang, Attorney-in-Fact
- Date
- 2026-07-13